Related Experiment Videos
Flavivirus DNA vaccines: current status and potential
G J Chang1, B S Davis, A R Hunt
1Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 80522, USA. gxc7@cdc.gov
Annals of the New York Academy of Sciences
|January 19, 2002
Summary
DNA vaccines offer a promising immunization strategy for flaviviruses like Japanese encephalitis and West Nile virus. Extracellular virus-like particles produced by these vaccines are key to inducing protective immunity.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- DNA-based vaccines represent a novel approach for flavivirus immunization.
- Previous attempts have targeted various flaviviruses, but factors influencing efficacy remain unclear.
Purpose of the Study:
- To investigate the efficacy of DNA vaccines against Japanese encephalitis virus (JEV) and West Nile virus (WNV).
- To elucidate the role of extracellular virus-like particles (VLPs) in eliciting protective immune responses.
Main Methods:
- Intramuscular immunization of mice and horses with DNA vaccines encoding JEV and WNV.
- Analysis of endogenous expression and secretion of VLPs.
- Correlation of VLP production with protective immunity.
Main Results:
- A single intramuscular DNA immunization protected mice and horses against JEV and WNV challenge.
- Recombinant plasmid vectors led to the expression and secretion of VLPs.
- VLP secretion correlated with the induction of protective immunity.
Conclusions:
- Extracellular VLPs composed of premembrane/membrane and envelope proteins are essential for protective immunity against flaviviruses.
- The transmembrane signal sequence of the premembrane protein influences protein processing and VLP conformation.
- DNA vaccines hold promise for multivalent and combination vaccines against multiple flaviviruses.